Skip to main content
OpenTrials
Completed

NCT Number: NCT01683227

Screening, Brief Intervention, and Referral to Treatment for Drug Use

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive, integrated public health approach to identify and deliver a spectrum of early detection and intervention services for substance use in general medical care settings. These settings, such as emergency department visits, offer a potential "teachable moment" because patients may have perceptions of vulnerability about their health, and therefore be particularly receptive to screening and counseling. There is mounting scientific evidence suggesting SBIRT is effective in reducing alcohol use at varying levels of severity in a myriad of health care settings including primary care, emergency departments, and trauma centers. Although the SBIRT approach has shown promise for alcohol, relatively little is known about its effectiveness for adult illicit drug use specifically.

This will be among the first studies to rigorously test the SBIRT approach for drug use. It will evaluate the effectiveness of SBIRT for drug use and related factors for 700 multi-ethnic ED patients using a two-group randomized repeated-measures design in which biologically-validated drug use abstinence and related outcomes of an intervention group are compared to those of an attention-placebo control group. Over a 14-month period, bilingual/bicultural Health Educators recruited participants who reported past 30-day illicit drug use in excess of risky alcohol use from the waiting areas of two large hospital's ED and trauma units. Following consent procedures and standardized baseline assessments, Health Educators randomly assigned participants to one of the two conditions. The intervention group received "Life Shift," an SBIRT drug use intervention matched to the participant's drug use risk level. The control group received the same type and quantity of intervention in an unrelated area-Driving and Traffic Safety ("Shift Gears" program), also matched to their driving/traffic risk level. A 6-month face-to-face follow-up visit by trained measurement technicians blind to the participant's assigned condition collected standardized self-report past 30-day drug use measures (ASI-Lite)and hair samples for validating self-reported abstinence. Additional outcome variables are changes in the frequency of drug use, functional status measures (i.e., medical problems, psychiatric problems, and alcohol use), and health care utilization.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Scripps Mercy Emergency Department and Trauma Unit, San Diego, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 or over
  • speak English or Spanish
  • competent to give consent and interact
  • drug use risk higher than alcohol use risk

Exclusion criteria

  • under 18
  • non english or spanish speaker
  • no telephone where one can be reached
  • too injured/sick to participate
  • alcohol use risk higher than drug use risk

Treatment and study plan

Screening/motivational drug intervention

Behavioral

Screening and brief motivational intervention delivered in the ER to reduce drug use

Other names: SBIRT

Motivational placebo intervention

Behavioral

Screening and brief motivational intervention delivered in the ER to reduce driving and traffic risk

Primary outcomes

  1. past 30 day drug use abstinence

    Time frame: 6 months post intervention

    Based on the addiction severity index-Lite

Secondary outcomes

  1. Frequency of drug use

    Time frame: 6 months post intervention

    Based on composite score from the Addiction Severity Index-Lite

Sponsors and collaborators

Lead sponsor

San Diego State University

Other

Registry information

Official study title

Screening and Brief Intervention for Latino and Non-Latino White Drug Users

Acronym: SBIRT

Important dates

Study start
2010
Primary completion
2011
Study completion
2012
First posted
Sep 11, 2012
Registry last updated
Apr 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.